These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10409444)

  • 1. Assessment of chromosome 8 copy number in cervical cancer by fluorescent in situ hybridization.
    Mark HF; Feldman D; Samy M; Sun C; Das S; Mark S; Lathrop J
    Exp Mol Pathol; 1999 Jun; 66(2):157-62. PubMed ID: 10409444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of chromosomal trisomies in prostate cancer using fluorescent in situ hybridization.
    Mark HF; Feldman D; Das S; Samy M; Sun CL; Mark S
    Exp Mol Pathol; 1999 Oct; 67(2):109-17. PubMed ID: 10527762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescent in situ hybridization study of c-myc oncogene copy number in prostate cancer.
    Mark HF; Samy M; Santoro K; Mark S; Feldman D
    Exp Mol Pathol; 2000 Feb; 68(1):65-9. PubMed ID: 10640455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trisomy 8 in stage I and stage III ovarian cancer detected by fluorescence in situ hybridization.
    Mark HF; Afify AM; Werness BA; Das S; Mark S; Samy M
    Exp Mol Pathol; 1999 Apr; 66(1):76-81. PubMed ID: 10331967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of chromosome aneuploidy in breast carcinoma progression by using fluorescence in situ hybridization.
    Mendelin J; Grayson M; Wallis T; Visscher DW
    Lab Invest; 1999 Apr; 79(4):387-93. PubMed ID: 10211991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aneusomy of chromosomes 7, 8, and 17 and amplification of HER-2/neu and epidermal growth factor receptor in Gleason score 7 prostate carcinoma: a differential fluorescent in situ hybridization study of Gleason pattern 3 and 4 using tissue microarray.
    Skacel M; Ormsby AH; Pettay JD; Tsiftsakis EK; Liou LS; Klein EA; Levin HS; Zippe CD; Tubbs RR
    Hum Pathol; 2001 Dec; 32(12):1392-7. PubMed ID: 11774175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence in situ hybridization study of HER-2/neu oncogene amplification in prostate cancer.
    Mark HF; Feldman D; Das S; Kye H; Mark S; Sun CL; Samy M
    Exp Mol Pathol; 1999 Jun; 66(2):170-8. PubMed ID: 10409446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome 4 deletions are frequent in invasive cervical cancer and differ between histologic variants.
    Sherwood JB; Shivapurkar N; Lin WM; Ashfaq R; Miller DS; Gazdar AF; Muller CY
    Gynecol Oncol; 2000 Oct; 79(1):90-6. PubMed ID: 11006038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HER-2/neu oncogene amplification in stage I and stage III ovarian papillary serous carcinoma.
    Afify AM; Werness BA; Mark HF
    Exp Mol Pathol; 1999 Jun; 66(2):163-9. PubMed ID: 10409445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal aneuploidy precedes morphological changes and supports multifocality in head and neck lesions.
    Ai H; Barrera JE; Meyers AD; Shroyer KR; Varella-Garcia M
    Laryngoscope; 2001 Oct; 111(10):1853-8. PubMed ID: 11801957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PCC and COBRA-FISH a new tool to characterize primary cervical carcinomas: to assess hall-marks and stage specificity.
    Darroudi F; Bergs JW; Bezrookove V; Buist MR; Stalpers LJ; Franken NA
    Cancer Lett; 2010 Jan; 287(1):67-74. PubMed ID: 19553004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aneuploidy of chromosome 8 detected by fluorescence in situ hybridisation in ACP01 cell line gastric adenocarcinoma.
    Costa Guimarães A; Gonçalves Quintana L; Ferreira Leal M; Satomi Takeno S; Pimentel Assumpção P; Moura Lima E; Salim Khayat A; Suchi Chen E; de Arruda Cardoso Smith M; Rodríguez Burbano R
    Clin Exp Med; 2006 Oct; 6(3):129-33. PubMed ID: 17061062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescent in situ hybridization in routinely processed bone marrow aspirate clot and core biopsy sections.
    Miranda RN; Mark HF; Medeiros LJ
    Am J Pathol; 1994 Dec; 145(6):1309-14. PubMed ID: 7992836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HER-2/neu oncogene amplification in cervical cancer studied by fluorescent in situ hybridization.
    Mark HF; Feldman D; Das S; Sun CL; Samy M; Lathrop J
    Genet Test; 1999; 3(2):237-42. PubMed ID: 10464675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of deletion to a 300 Kb interval of chromosome 11q13 in cervical cancer.
    Srivatsan ES; Chakrabarti R; Zainabadi K; Pack SD; Benyamini P; Mendonca MS; Yang PK; Kang K; Motamedi D; Sawicki MP; Zhuang Z; Jesudasan RA; Bengtsson U; Sun C; Roe BA; Stanbridge EJ; Wilczynski SP; Redpath JL
    Oncogene; 2002 Aug; 21(36):5631-42. PubMed ID: 12165862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of gene expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
    Contag SA; Gostout BS; Clayton AC; Dixon MH; McGovern RM; Calhoun ES
    Gynecol Oncol; 2004 Dec; 95(3):610-7. PubMed ID: 15581972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression/amplification of HER-2/neu is uncommon in invasive carcinoma of the uterine cervix.
    Rosty C; Couturier J; Vincent-Salomon A; Genin P; Fréneaux P; Sigal-Zafrani B; Sastre-Garau X
    Int J Gynecol Pathol; 2004 Jan; 23(1):13-7. PubMed ID: 14668544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of Her-2/Neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization.
    Jimenez RE; Wallis T; Tabasczka P; Visscher DW
    Mod Pathol; 2000 Jan; 13(1):37-45. PubMed ID: 10658908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Numerical change of 7, 17 and Y chromosomes in human lung carcinoma detected by fluorescence in situ hybridization].
    Zhang J; Chen L; Lü Y
    Zhonghua Bing Li Xue Za Zhi; 1997 Dec; 26(6):356-9. PubMed ID: 10374327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.